- TitleGroup President of the Pfizer Biopharmaceuticals Group
- 2019 Rank-
Hwang isn’t just the president of Pfizer’s sprawling biopharmaceuticals unit—she’s the leader of a business that brings in 80% of Pfizer’s $52 billion in annual revenue. She oversees 26,000 employees and runs a unit that impacted the lives of 434 million people in 125 countries in 2019. She also has direct influence in planning the logistics of Pfizer’s COVID vaccine efforts, such as how to best cool the treatment so it may safely be transported, should it prove effective. Education, too, is important to Hwang, who is planning a direct-to-consumer campaign to instill confidence in a COVID vaccine. And did we mention the buzz that she’s in line to succeed CEO Albert Bourla?
Subscribe to The Broadsheet, our newsletter on the world’s most powerful women.